UB Paderborn / Katalog / Suche / in CDI

1 – 25 von 2.996

Sortiert nach

Linc00941 fuels ribogenesis and protein synthesis by supporting robust cMYC translation in malignant pleural mesothelioma

Cancer letters, 2024-06, Vol.592, p.216950, Article 216950

2024

Volltextzugriff (PDF)

Molecular and Immunohistochemical Testing in Mesothelioma and Other Mesothelial Lesions

Archives of pathology & laboratory medicine (1976), 2024-05, Vol.148 (5), p.e77-e89

2024

Volltextzugriff (PDF)

Mesothelioma-Associated Fibroblasts Modulate the Response of Mesothelioma Patient-Derived Organoids to Chemotherapy via Interleukin-6

International journal of molecular sciences, 2024-05, Vol.25 (10), p.5355

2024

Volltextzugriff (PDF)

L1CAM expression in cystic mesothelial lesions: a comparison with adenomatoid tumours, well‐differentiated papillary mesothelial tumours and malignant mesotheliomas

Histopathology, 2021-08, Vol.79 (2), p.272-274

2021

Volltextzugriff (PDF)

Defining and targeting tumor-associated macrophages in malignant mesothelioma

Proceedings of the National Academy of Sciences - PNAS, 2023-02, Vol.120 (9), p.e2210836120-e2210836120

2023

Volltextzugriff (PDF)

Mesothelioma-associated fibroblasts enhance proliferation and migration of pleural mesothelioma cells via c-Met/PI3K and WNT signaling but do not protect against cisplatin

Journal of experimental & clinical cancer research, 2023-01, Vol.42 (1), p.27-27, Article 27

2023

Volltextzugriff (PDF)

Pleural mesothelioma from fluoro-edenite exposure: PACAP and PAC1 receptor. A preliminary report

European journal of histochemistry, 2024-05, Vol.68 (2)

2024

Volltextzugriff (PDF)

Can novel adipokines, asprosin and meteorin-like, be biomarkers for malignant mesothelioma?

Biotechnic & histochemistry, 2020-04, Vol.95 (3), p.171-175

2020

Volltextzugriff (PDF)

Intercellular interaction dictates cancer cell ferroptosis via NF2-YAP signalling

Nature (London), 2019-08, Vol.572 (7769), p.402-406

2019

Volltextzugriff (PDF)

The role of 18F-FDG-PET/ceCT in peritoneal mesothelioma

Nuclear medicine communications, 2017-04, Vol.38 (4), p.312-318

2017

Volltextzugriff (PDF)

Regional delivery of mesothelin-targeted CAR T cell therapy generates potent and long-lasting CD4-dependent tumor immunity

Science translational medicine, 2014-11, Vol.6 (261), p.261ra151

2014

Volltextzugriff (PDF)

Guidelines for Pathologic Diagnosis of Malignant Mesothelioma 2017 Update of the Consensus Statement From the International Mesothelioma Interest Group

Archives of pathology & laboratory medicine (1976), 2018-01, Vol.142 (1), p.89-108

2018

Volltextzugriff (PDF)

Tumor Suppressor microRNAs Contribute to the Regulation of PD-L1 Expression in Malignant Pleural Mesothelioma

Journal of thoracic oncology, 2017-09, Vol.12 (9), p.1421-1433

2017

Volltextzugriff (PDF)

Exploiting the folate receptor α in oncology

Nature reviews. Clinical oncology, 2020-06, Vol.17 (6), p.349-359

2020

Volltextzugriff (PDF)

Analysis of expression of programmed cell death 1 ligand 1 (PD-L1) in malignant pleural mesothelioma (MPM)

PloS one, 2015-03, Vol.10 (3), p.e0121071-e0121071

2015

Volltextzugriff (PDF)

Iron addiction with ferroptosis-resistance in asbestos-induced mesothelial carcinogenesis: Toward the era of mesothelioma prevention

Free radical biology & medicine, 2019-03, Vol.133, p.206-215

Toyokuni, Shinya

2019

Volltextzugriff (PDF)

Tumor PD-L1 expression in malignant pleural and peritoneal mesothelioma by Dako PD-L1 22C3 pharmDx and Dako PD-L1 28-8 pharmDx assays

Human pathology, 2019-05, Vol.87, p.11-17

2019

Volltextzugriff (PDF)

Novel therapies for malignant pleural mesothelioma

The lancet oncology, 2018-03, Vol.19 (3), p.e161-e172

2018

Volltextzugriff (PDF)

Human CAR T cells with cell-intrinsic PD-1 checkpoint blockade resist tumor-mediated inhibition

The Journal of clinical investigation, 2016-08, Vol.126 (8), p.3130-3144

2016

Volltextzugriff (PDF)

A combination of MTAP and BAP1 immunohistochemistry is effective for distinguishing sarcomatoid mesothelioma from fibrous pleuritis

Lung cancer (Amsterdam, Netherlands), 2018-11, Vol.125, p.198-204

2018

Volltextzugriff (PDF)

Clinical and molecular validation of BAP1, MTAP, P53, and Merlin immunohistochemistry in diagnosis of pleural mesothelioma

Modern pathology, 2022-10, Vol.35 (10), p.1383-1397

2022

Volltextzugriff (PDF)

Novel insights into mesothelioma biology and implications for therapy

Nature reviews. Cancer, 2017-08, Vol.17 (8), p.475

2017

Volltextzugriff (PDF)

The prognostic significance of BAP1, NF2, and CDKN2A in malignant peritoneal mesothelioma

Modern pathology, 2016-01, Vol.29 (1), p.14-24

2016

Volltextzugriff (PDF)

Restoring expression of miR-16: a novel approach to therapy for malignant pleural mesothelioma

Annals of oncology, 2013-12, Vol.24 (12), p.3128-3135

2013

Volltextzugriff (PDF)

1 – 25 von 2.996

Suche als RSS-Feed

Aktive Filter

PublikationsformNewsletter-Artikel

Nur zeigenMit Volltextzugriff

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(2.754)

Publikationsform

Sprache

10 weitere anzeigen...

Weniger anzeigen...

Erscheinungsjahr

n.n

Thema

15 weitere anzeigen...

Weniger anzeigen...

Kollektion

MEDLINE
(2.936)
EZB Electronic Journals Library
(1.799)
Ingenta
(1.388)
LWW Total
(1.186)
IngentaConnect Journals
(836)
NUS Single-Journal Subscriptions
(634)
Wiley-Blackwell Journals
(473)
ScienceDirect
(453)
Wiley Online Library Full Collection 2018
(349)
Elsevier Journal Backfiles on ScienceDirect (DFG Nationallizenzen)
(328)
SpringerLink Journals
(286)
Nature_系列刊
(213)
SpringerLINK Contemporary (Konsortium Baden-Württemberg)
(150)
Nexis Uni
(134)
Access via Taylor & Francis
(118)
Taylor & Francis
(106)
Taylor & Francis Online
(93)
Oxford University Press Journals Current
(86)
Oxford Journals 2020 Medicine
(77)
BMJ journals single titles
(56)

15 weitere anzeigen...

Weniger anzeigen...

Zeitschrift / Serie

Plos One
(121)
Cancer Research
(61)
Lung Cancer
(60)
International Journal Of Molecular Sciences
(59)
Journal Of Thoracic Oncology
(59)
Clinical Cancer Research
(54)
Histopathology
(51)
International Journal Of Cancer
(46)
Human Pathology
(44)
Oncotarget
(44)

5 weitere anzeigen...

Weniger anzeigen...

Neu hinzugefügt

... seit 30 Tagen
(1)
... seit 90 Tagen
(3)

Menü

Weitere Dienste

Einstellungen

Linc00941 fuels ribogenesis and protein synthesis by supporting robust cMYC translation in malignant pleural mesothelioma

Molecular and Immunohistochemical Testing in Mesothelioma and Other Mesothelial Lesions

Mesothelioma-Associated Fibroblasts Modulate the Response of Mesothelioma Patient-Derived Organoids to Chemotherapy via Interleukin-6

L1CAM expression in cystic mesothelial lesions: a comparison with adenomatoid tumours, well‐differentiated papillary mesothelial tumours and malignant mesotheliomas

Defining and targeting tumor-associated macrophages in malignant mesothelioma

Mesothelioma-associated fibroblasts enhance proliferation and migration of pleural mesothelioma cells via c-Met/PI3K and WNT signaling but do not protect against cisplatin

Pleural mesothelioma from fluoro-edenite exposure: PACAP and PAC1 receptor. A preliminary report

Can novel adipokines, asprosin and meteorin-like, be biomarkers for malignant mesothelioma?

Intercellular interaction dictates cancer cell ferroptosis via NF2-YAP signalling

Comprehensive genomic analysis of malignant pleural mesothelioma identifies recurrent mutations, gene fusions and splicing alterations

The role of 18F-FDG-PET/ceCT in peritoneal mesothelioma

Regional delivery of mesothelin-targeted CAR T cell therapy generates potent and long-lasting CD4-dependent tumor immunity

Guidelines for Pathologic Diagnosis of Malignant Mesothelioma 2017 Update of the Consensus Statement From the International Mesothelioma Interest Group

Tumor Suppressor microRNAs Contribute to the Regulation of PD-L1 Expression in Malignant Pleural Mesothelioma

Exploiting the folate receptor α in oncology

Analysis of expression of programmed cell death 1 ligand 1 (PD-L1) in malignant pleural mesothelioma (MPM)

Iron addiction with ferroptosis-resistance in asbestos-induced mesothelial carcinogenesis: Toward the era of mesothelioma prevention

Tumor PD-L1 expression in malignant pleural and peritoneal mesothelioma by Dako PD-L1 22C3 pharmDx and Dako PD-L1 28-8 pharmDx assays

Novel therapies for malignant pleural mesothelioma

Human CAR T cells with cell-intrinsic PD-1 checkpoint blockade resist tumor-mediated inhibition

A combination of MTAP and BAP1 immunohistochemistry is effective for distinguishing sarcomatoid mesothelioma from fibrous pleuritis

Clinical and molecular validation of BAP1, MTAP, P53, and Merlin immunohistochemistry in diagnosis of pleural mesothelioma

Novel insights into mesothelioma biology and implications for therapy

The prognostic significance of BAP1, NF2, and CDKN2A in malignant peritoneal mesothelioma

Restoring expression of miR-16: a novel approach to therapy for malignant pleural mesothelioma

Aktive Filter

Suchergebnisse filtern